Clinical Trial Update: Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia (SFBRI) [NA]

View source ↗

Summary

A terminated clinical trial evaluated cognitive outcomes with aripiprazole (Abilify) in patients with schizophrenia and schizoaffective disorder. The study stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Abilify (aripiprazole)

Snippet

Sponsor: Louisiana State University Health Sciences Center Shreveport | Conditions: Schizophrenia, Schizoaffective Disorder | NA | Status: TERMINATED